Featured Articles
Read our latest stories on the people and scientific innovations making a difference in patients’ lives.
Science & Innovation
A Picture of Pain: What Life is Really Like with Chronic Pain
Almost everyone has experienced some type of acute, or temporary, pain in their lives. Acute pain is a protective response to tissue injury that typically resolves with the healing process and lasts less than three months. However, for one in five people around the world, their pain persists for longer than three months and is considered chronic. , Some people may suffer from diseases or disorders that cause their chronic pain, while others may have an injury or accident that causes long-term...
Science & Innovation
Collection and Use of Real-World Data Continues to Grow Around the World
Conducting real-world data (RWD) analyses to generate real-world evidence (RWE) is a growing practice in the healthcare community. RWE provides helpful information that complements clinical trial findings and may help fill knowledge gaps related to how a medication is used in real-world medical settings. These data consist of de-identified patient-related data collected from various sources, including but not limited to, anonymized electronic medical records, claims databases, health surveys...
Science & Innovation
Turning the Promise of Gene Therapy into a Reality
Pfizer's Rare Disease team is focusing on highly specialized, potential gene therapy treatments, and clinical trials are underway to explore the potential of gene therapy. By targeting the underlying cause of a genetic disease, Pfizer hopes to restore normal function in affected tissues or cells, which could potentially enable a patient to manage his or her disease without the need for ongoing treatments. If Pfizer is successful, imagine the possibilities. How do you translate disease...
Science & Innovation
Imagine the Possibilities: Gene Therapy
Genes play an essential role in determining the function of each cell in the body, making up 30 million codes of DNA. If even one of these codes is damaged, a genetic alteration may occur causing a genetic disease. Gene therapy has the potential to significantly improve the lives of people who have genetic diseases caused by genetic alterations, some of which can be debilitating and life-threatening. Pfizer Rare Disease is focusing on highly specialized, potentially one-time gene...
Science & Innovation
One Family’s Hemophilia Journey
This microdocumentary shares the moving story of a family with two young sons who have severe hemophilia, giving us a glimpse into their history and treatment routine. Hemophilia is a rare bleeding disorder in which the body is unable to properly create a blood clot. Beyond external bleeding, like a cut, people with hemophilia also bleed internally and in their joints, which can lead to crippling arthritis later in life. The story highlights the significant progress made in this therapeutic...
Science & Innovation
Tackling Antibiotic Resistance
Pfizer and industry partners present roadmap for overcoming the threat that resistance poses. In an unprecedented collaboration, today, Pfizer and 13 industry partners released a comprehensive plan of action that lays out four key commitments we pledge to deliver by 2020 to reduce the rising incidence of antimicrobial resistance. Antimicrobial resistance is a natural process by which bacteria and other microbes develop resistance to the drugs commonly used to treat infections, including...
Science & Innovation
The World Federation of Hemophilia Twinning Program
Celebrating Advancements in Hemophilia Patient Care and Treatment In 1994, the World Federation of Hemophilia (WFH) recognized the need for a program to unite hemophilia treatment centers and patient organizations across the world to share information, best practices, and resources to help improve the treatment and care of those living with hemophilia. As a result, the WFH Twinning Program was created to facilitate short-term collaborative partnerships between medical professionals and...
Media Resources & Contact Information
Anyone may view our press releases, press statements, and press kits. However, to ensure that customers, investors, and others receive the appropriate attention, Pfizer Media Contacts may only respond to calls and emails from professional journalists.